Knott David M Jr Cidara Therapeutics, Inc. Transaction History

Knott David M Jr

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.45 - $13.0 $22,847 - $660,049	50,773 Added 7.99%	686,027 $431,000
Q2 2022 Aug 11, 2022	BUY	$0.43 - $0.91 $24,123 - $51,051	56,100 Added 9.69%	635,254 $310,000
Q1 2022 May 16, 2022	BUY	$0.67 - $1.39 $100,672 - $208,858	150,258 Added 35.03%	579,154 $482,000
Q4 2021 Feb 11, 2022	BUY	$1.18 - $2.18 $506,097 - $934,993	428,896 New	428,896 $545,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.63B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.